|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Preclinical activity of ABT- 869, a muhitargeted receptor tyrosine kinase inhibitor 显示文摘 | Albert DH Tapang P Magoc TJ | 2006 | Mol Cancer Ther2006，5，4： | 1 |
| 2 | Preclinical activity of ABT-869, a multitargeted receptor tyroslne kinase inhibitor显示文摘 | ALBERT D H TAPANG P MAGOC T J | 2006 | Mol Cancer Ther2006，5，4： | 1 |
| 3 | Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of P53-defective,oncogenic transformed cells and inhibits tumor growth in animals显示文摘 | Guan R Tapang P Leverson JD | 2005 | Cancer Res2005，65，7： | 1 |
| 4 | Identification of genes that confer tumor cell resistance to the aurora B kinase inhibitor, AZD 1152显示文摘 | Guo J Anderson MG Tapang P | 2009 | Pharmacogenomics J2009，9，2： | 1 |
| 5 | Preclinical activity of ABT-869,a multitargeted receptor tyrosine kinase inhibitor显示文摘 | Albert DH Tapang P Pease LJ | | 0，，04： | 1 |
| 6 | ABT-869, amultitargeted receptor tyrosine kinase inhibitor: in-hibition of FLT3 phosphorylation and signaling in a-cute myeloid leukemia 显示文摘 | Shankar DB Li JL Tapang P | 2007 | Blood2007，109，8： | 1 |
| 7 | Preclinicai activity of ABT-869,a muhitargeted receptor tyrosine kinase inhibitor 显示文摘 | ALBERT DH TAPANG P MAGOC TJ | 2006 | Mol Cancer Ther2006，5，4： | 1 |
| 8 | Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor显示文摘 | ALBERT DH TAPANG P MAGOC TJ | 2006 | Mol Cancer Ther2006，5，4： | 1 |
| 9 | ABT-869 multi-targeted receptor tyrosine kinase inhibitor:inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia显示文摘 | Shankar DB Li J Tapang P | 2007 | Blood2007，109，： | 1 |
| 10 | ABT-869,a muhitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia显示文摘 | Shankar D B Li J Tapang P Owen McCall J Pease L J Dai Y | 2007 | Blood2007，109，： | 1 |
| 11 | The role ofplateletactivating factor (PAF) and the efficacy ofABT-491, a highly potent and selective PAF antagonist, in experimental allergic rhinitis显示文摘 | Albert DH Malo PE Tapang P | 1998 | J Pharmacol Exp Ther1998，284，1： | 1 |
| 12 | Preclinical activity of ABT-869, a multi-targeted receptor tyrosine kinase inhibitor显示文摘 | Albert DH Tapang P Magoc TJ | 2006 | Mol Cancer Ther2006，5，4： | 1 |
| 13 | Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor显示文摘 | ALBERT D H TAPANG P MAGOC T J | 2006 | Mol Cancer Ther2006，5，99： | 1 |
| 14 | Preclinical activity of ABT-869, a mnititargeted receptor tyrosine kinase inhibitor显示文摘 | ALBERT D H TAPANG P MAGOC T J | 2006 | Mol Cancer Ther2006，5，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员